Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Risk Factor Profiles May Differ Between Younger‐Onset and Late‐Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort
Lucas Wigston; Muktar Ahmed; Zegeye Abebe; Stephen J. Pandol; Yohannes Adama Melaku; Savio George BarretoShow moreShow less
1. Flinders Health and Medical Research Institute, College of Medicine and Public Health Flinders University Adelaide Australia; 2. Division of Digestive and Liver Diseases Cedars‐Sinai Medical Centre Los Angeles California USA; 3. University of California Los Angeles California USA; 4. Division of Surgery and Perioperative Medicine Flinders Medical Centre Adelaide AustraliaShow moreShow less
Transarterial Chemoembolization and Chemo‐Immunoembolization in Locally Advanced Rectal Cancer: An Updated Systematic Review
Omar Abu Saadeh; Hugo C. Temperley; Niall J. O'Sullivan; Benjamin M. Mac Curtain; Kevin P. Sheahan; Julian Soares; Michael E. Kelly; Satish Warrier; Zi Qin NgShow moreShow less
1. Royal College of Surgeons in Ireland Dublin Ireland; 2. Department of Radiology St. James's Hospital Dublin Ireland; 3. Trinity St James Cancer Institute St James Hospital Dublin 8 Ireland; 4. Northwell Health, New Hyde Park New York New York USA; 5. Department of Urology Lenox Hill Hospital New York New York USA; 6. Department of Radiology Royal Perth Hospital Perth Australia; 7. Department of Surgery Trinity College Dublin University of Dublin Dublin 2 Ireland; 8. School of Medicine Trinity College Dublin Dublin 2 Ireland; 9. Department of Surgery Austin Health Heidelberg Australia; 10. Department of Surgery University of Melbourne Melbourne Australia; 11. International Medical Robotics Academy (IMRA) Melbourne Australia; 12. Department of Surgery Peter MacCallum Cancer Centre Melbourne Australia; 13. Department of Surgery The Alfred Hospital Melbourne Australia; 14. Department of General Surgery Royal Perth Hospital Perth Australia; 15. School of Surgery University of Western Australia Perth AustraliaShow moreShow less
Real‐World Toxicity and Outcomes of KEYNOTE‐522‐Style Neoadjuvant Pembrolizumab for Triple‐Negative Breast Cancer in Australia
Evon Jude; Sarah Jaboury; Qing Ze Fang; Josephine Stewart; Frances Barnett; Bianca Devitt; Belinda YeoShow moreShow less
1. Austin Health Melbourne Australia; 2. Olivia Newton‐John Cancer Research Institute Melbourne Australia; 3. Western Health Melbourne Australia; 4. Eastern Health Clinical School Monash University Melbourne Australia; 5. Northern Health Melbourne Australia; 6. Eastern Health Melbourne AustraliaShow moreShow less
Divergent Trends in Head and Neck Cancer Burden in China (1990–2021)
Ming Tang; Kaitai Liu; Zhuo Wu; Yihui Yang; Zhoushu Zheng; Changzeng Zhou; Yongbo Zhang; Xiaoyan LiShow moreShow less
1. Department of Otolaryngology Head and Neck Surgery The Affiliated Women and Children's Hospital of Ningbo University Ningbo P. R. China; 2. Department of Radiation Oncology Ningbo Medical Center Lihuili Hospital Ningbo China; 3. Department of Otorhinolaryngology Head and Neck Surgery School of Medicine Shanghai Children's Hospital, Shanghai Jiao Tong University Shanghai ChinaShow moreShow less
Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment
Tamotsu Sagawa; Masahiro Hirakawa; Hiroyuki Nagashima; Koshi FujikawaShow moreShow less
1. Department of Gastroenterology National Hospital Organization Hokkaido Cancer Center Sapporo Japan; 2. Division of Medical Oncology Department of Internal Medicine Sapporo Medical University School of Medicine Sapporo JapanShow moreShow less
Re: “Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer.”
Gharbi LassadShow moreShow less
1. Mongi Slim Hospital Tunis Tunisia; 2. University Medicine Tunis Tunis TunisiaShow moreShow less
FAQ
How long does Asia-Pacific Journal of Clinical Oncology take to review a manuscript?
As of 2026-11-17, CrushSCI has 20 complete review records for Asia-Pacific Journal of Clinical Oncology. The fastest paper went from submission to acceptance in 2 days (Response Letter: Re: “Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer”, received 2026-10-12, accepted 2026-10-14); the slowest took 490 days. The average is 172 days and the median is 153 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
